Thematic Ideas: Testing, Inspection and Certification (TIC)
The best stocks in one of the world's most boring sectors
The Testing, Inspection and Certification (TIC) industry is arguably one of the most boring sectors on the planet. However, for the disciplined quality investor, boring is synonymous with lucrative. TIC companies operate an exceptional business model: asset-light, structurally moated and backed by legally mandated, recurring revenue streams.
In this deep dive, we break down the global TIC market and run a comprehensive, framework-driven analysis on the industry’s 6 main companies using our Quality Stocks Investment Framework:
Eurofins Scientific (France)
Bureau Veritas (France)
SGS SA (Switzerland)
UL Solutions (USA)
ALS Limited (Australia)
Intertek Group (UK)
For paid subscribers, we take the analysis one step further. Beyond identifying individual stock ideas, I apply the full Quality Stocks Investment Framework, including thematic screeners based on the Quality Stocks Score, fair value estimates, detailed Total Shareholder Return (TSR) breakdowns, defined buy zones and my investment verdict (Attractive / Conditional / Unattractive). This added layer is designed to bridge the gap between high-level insights and actual execution, helping long-term investors make more disciplined and risk-aware decisions.
At the end of this article, I will reveal exactly which one of these 6 compounders is officially being added to my portfolio this month.
If you enjoy Thematic Selections, be sure to check out the latest editions
Why Look at TIC Right Now?
1. The Defensive Growth Cushion
We are operating in a macroeconomic environment where household purchasing power is showing visible signs of strain, credit delinquencies are ticking up and the cost of capital remains persistently high. In a slowing economy, discretionary consumer spending dries up.
The TIC basket benefits from non-discretionary, legally mandated demand. If a shipping vessel needs its hull structurally certified to sail, a food supplier requires contamination screening to pass customs or an electrical component needs safety marks before hit retail shelves, the service happens regardless of GDP growth or interest rate hikes. This regulatory cushion gives these businesses bond-like defensive qualities during market downturns, while their commercial pricing power protects their high margins from inflationary pressures.
2. The Unstoppable Regulatory Tailwind
Aside from their defensive resilience, the long-term compounding thesis for this sector is backed by the most predictable macroeconomic trend in existence: an exponentially multiplying global regulatory burden (used for customer safety and for hidden protectionism).
Every single year, governments introduce stricter environmental mandates, harsher product safety codes, and new ESG requirements (like Europe’s Corporate Sustainability Reporting Directive). The global TIC market is projected to expand toward a $300B absolute pool over the next decade. By investing in these pick-and-shovel enablers, you are taking the underwriter’s position on global compliance. Whether a company is measuring toxic PFAS “forever chemicals” in a local water grid or auditing supply chain carbon footprints, the companies in our screener collect a toll on every single transaction.
3. Switching Costs (The Laboratory Network Lock-in)
In most industries, customers can jump to a competitor if a cheaper or slightly better option comes along. In the compliance world, making a switch can be difficult because of logistics or regulation.
Once a multinational manufacturer integrates its global supply chain workflows into a specific TIC vendor’s proprietary auditing software or laboratory network, the cost of ripping out that infrastructure is high. It requires retraining compliance teams, re-mapping data integrations across multi-country export facilities and risking friction with strict local customs authorities who already trust the incumbent’s testing stamp. The operational friction and legal risk of an uncertified product shipment create a decent customer retention mechanism.
4. The Recurrence
TIC enablers enjoy a reliable form of recurring revenue: legally mandated physical sample volume.
Take the geochemistry and mineral division of ALS Limited as a prime example. They own the highly specialized hub-and-spoke laboratory networks near global mining hubs. When mining exploration companies drill for core samples, they are legally required to route physical core segments through accredited labs to verify ore grades for public financial markets. The mine literally cannot raise capital or report reserves without purchasing these ongoing testing cycles. Similarly, consumer product testers like Intertek or UL Solutions see forced recurrence as clients refresh consumer electronics or apparel line-ups every season, every new SKU requires a brand new round of certification.
5. Extreme Fragmentation & M&A
Despite being dominated on the public markets by a handful of prominent multi-billion dollar names, the global TIC landscape is fragmented. The top ten largest companies combined control less than 25% of the total market. The remaining 75% of the industry is a vast ocean of tens of thousands of local, owner-operated laboratories, family-owned inspection businesses or regional certification boutiques.
This extreme fragmentation is the ultimate playground for an institutional serial acquirer. And all the companies we highlight run a continuous M&A strategy.
The 6 stocks
Eurofins Scientific (France) is the global powerhouse of laboratory-based bio-analysis, purposefully avoiding physical field inspections to construct an elite network of state-of-the-art labs for food, environmental and pharmaceutical testing. Driven historically by a hyper-aggressive, founder-led M&A machine that absorbed over 900 laboratories, the company built an unmatched scale moat that competitors cannot easily replicate. Having completed its multi-year capital expenditure push, Eurofins is currently executing a clear pivot toward organic optimization and digital infrastructure harmonization.
Bureau Veritas (France) stands out as a highly stable multi-specialist compounder, supported by its dominant positions in building infrastructure compliance and global marine fleet classification. The core economic engine behaves like a premium utility, once a multi-million dollar container ship or structural asset is stamped by BVI, that certification acts as a mandatory passport for international trade and insurance frameworks. While its labor-intensive field inspection wings render it slightly more exposed to short-term foreign exchange fluctuations, its underlying structural backlog remains exceptionally defensive.
SGS (Switzerland) is the largest traditional Testing, Inspection and Certification incumbent by revenue. It operates an unrivaled network stretching across global agricultural and mineral trade routes. While historically viewed by quality investors as a slow-moving, GDP-indexed giant with uninspiring capital efficiency, the company is undergoing an aggressive operational transformation under new leadership. Shifting away from low-margin, fragmented regional roll-ups, SGS inflected its strategy by executing a massive $1.3B acquisition of Applied Technical Services (ATS). This move repositions their capital allocation engine directly into higher-margin, high-barrier industrial, aerospace and safety testing niches across North America.
UL Solutions (USA) is the premium asset of the public TIC sector, maintaining a near-impenetrable safety monopoly through its gold-standard “UL Listed” validation mark. Manufacturers are effectively legally mandated to secure UL’s certification before selling consumer electronics, smart home appliances or commercial hardware in the United States. Spun out via a successful IPO, the company leverages its exceptional EBITDA margin profile and robust free cash flow generation to fund aggressive geographic expansions into Europe and Asia. Its structural growth is strongly protected by rapid product lifecycle refreshes and sweeping secular tailwinds in EV battery safety and smart grid electrification.
ALS Limited (Australia) operates a dynamic and high-growth framework, fundamentally anchored by its position as the global number-one laboratory network for geochemistry and mining mineral analysis. Recognizing the inherent cyclicality of resource exploration, management has successfully executed a multi-year capital reallocation program. They deployed substantial cash into downstream, non-cyclical Life Sciences assets, including the strategic integration of Nuvisan in European pharma and Wessling in European environmental testing. While these large acquisitions have caused minor, temporary dilutions to group margins, they give ALS an exceptional runway to capture market share in high-margin pharmaceutical development and global clean water testing.
Intertek Group (UK) has deliberately bypassed heavy commodity field testing to focus on high-value retail, apparel and consumer product supply chain assurance. By embedding its proprietary “Total Quality Assurance” software and auditing solutions directly into the supply chains of premium global brands, Intertek commands superior pricing power and structural EBITDA margins exceeding 21%. Rather than chasing capital-intensive laboratory footprints, Intertek allocates its free cash flow exclusively toward light-asset software additions and global compliance advisory platforms.
Unlock the Full Analysis. For each of the 6 stocks, I apply the Quality Stocks Investment Framework in full:
Quality Score-based screener
Fair value estimates & detailed Total Shareholder Return (TSR) breakdowns
Defined buy zones
And a clear investment verdict: Attractive, Conditional or Unattractive
This is where insights turn into action
